Doron Steinberg
Overview
Explore the profile of Doron Steinberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
1528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sionov R, Korem M, Polacheck I, Steinberg D
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001381
: is a natural inhabitant of the vagina, but when an imbalance occurs in the vaginal microbiota, this bacterium can cause vaginosis, a condition that must be treated when symptomatic...
2.
Aldeen Salaymeh E, Steinberg D, Abu Ammar A
Int J Pharm
. 2024 Dec;
670:125143.
PMID: 39732215
Chlorhexidine (CHX) is a gold standard therapeutic agent against clinical oral pathogens. However, its oral use is limited due to unpleasant taste, alteration in taste buds, staining of teeth and...
3.
Sebbane N, Abramovitz I, Kot-Limon N, Steinberg D
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597686
Background: Endodontic treatment failures are often linked to the persistence of in the root canal system. This study aimed to investigate the antibacterial/antibiofilm mechanism of chlorhexidine (CHX), particularly at low...
4.
Haj-Yahya F, Steinberg D, Sionov R
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519322
Background: and are Gram-positive bacteria involved in the development of dental caries, as they are able to form biofilms on tooth enamel, ferment sugars into acids, and survive under acidic...
5.
Ofori P, Zemliana N, Zaffran I, Etzion T, Sionov R, Steinberg D, et al.
Pharmacol Res
. 2024 Oct;
209:107441.
PMID: 39368567
Abnormal cannabinoids (including comp 3) are a class of synthetic lipid compounds with non-psychoactive properties and regioisomer configurations, but distinct from traditional cannabinoids since they do not interact with the...
6.
Melkam A, Sionov R, Shalish M, Steinberg D
Antibiotics (Basel)
. 2024 Jun;
13(6).
PMID: 38927206
Dental caries is a global health problem that requires better prevention measures. One of the goals is to reduce the prevalence of the cariogenic Gram-positive bacterium . We have recently...
7.
Chamlagain M, Hu J, Sionov R, Steinberg D
Front Microbiol
. 2024 Apr;
15:1333274.
PMID: 38596377
is a Gram-positive, facultative anaerobic bacterium, which causes dental caries after forming biofilms on the tooth surface while producing organic acids that demineralize enamel and dentin. We observed that the...
8.
Abudalu M, Aqawi M, Sionov R, Friedman M, Gati I, Munz Y, et al.
Pharmaceuticals (Basel)
. 2023 May;
16(5).
PMID: 37242528
Synthetic surgical meshes are commonly used in abdominal wall reconstruction surgeries to strengthen a weak abdominal wall. Common mesh-related complications include local infection and inflammatory processes. Because cannabigerol (CBG) has...
9.
Wolfson G, Sionov R, Smoum R, Korem M, Polacheck I, Steinberg D
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047147
is a cariogenic bacterium in the oral cavity involved in plaque formation and dental caries. The endocannabinoid anandamide (AEA), a naturally occurring bioactive lipid, has been shown to have anti-bacterial...
10.
Cataldo Russomando A, Steinberg D, Gati I, Sionov R, Eliashar R, Friedman M, et al.
Pharmaceutics
. 2023 Mar;
15(3).
PMID: 36986875
The aim of the study was to develop a sustained-release varnish (SRV) containing mometasone furoate (MMF) for sinonasal stents (SNS) to reduce mucosa inflammation in the sinonasal cavity. The SNS'...